• Nanomol congratulates Dr. Adriana Kyvik on the obtainment of her PhD

    Dr. Adriana Kyvik defended her thesis entitled "Self assembled monolayer for biological applications: design, processing, characterization and biological studies", on 25th of January and supervised by Dr. Imma Ratera.
  • Nanomol researchers obtain funding from La Marató TV3 for a project on infectious diseases

    Nanomol group has obtained funding from La Marató (TV3) for a project on infectious diseases. The project is entitled "Prevention of infections related to vascular catheters by means of the functionalization of catheters impregnated with thermally switchable hydrogels with broad spectrum antimicrobials (FUNCATH)" and is coordinated by the medical doctor Oriol Gasch from Parc Taulí. The contribution of the Nanomol group is lead by Dr. Imma Ratera.

  • Nanomol congratulates Dr. Toni Campos on the obtainment of his PhD

    Dr. Toni Campos obtained his PhD on the 11th October with the thesis entitled "Influence of Organic Semiconductors Morphology, Structure and Processability on the Organic Field-Effect Transistors Performance" supervised by Dr. Marta Mas-Torrent.

     

     

  • Nanomol congratulates Dr. Francesc Bejarano on the obtainment of his PhD

    Dr. Francesc Bejarano obtained his PhD on 26th october with his thesis entitled "Molecular conductors and switches for electronics: in solution and on surface studies", supervised by Dr. Núria Crivillers Clusella and Prof. Concepció Rovira Angulo.

     

  • Congratulations to Serena Maglioni on the obtainment of her PhD!

    Serena Maglione had the viva voce of her thesis "Preparation of electroactive self-assembled monolayers for the fabrication of advanced electronic devices" on Friday 27th April. The supervisors of her work were Concepció Rovira and Marta Mas-Torrent from the Nanomol group.

  • NANOMOL Collaborates With Almirall And Leitat Technology Center In Nanomedicine Applied To Dermatology

    Nano4Derm involves the development and physico-chemical and biological characterisation of nanocapsules containing active ingredients, and the generation of scalable formulation prototypes for manufacturing nanoformulations suitable for clinical trials. These innovative formulations will address current unmet needs and challenges, such as antimicrobial resistance, and provide improved topical treatments for Acne and Psoriasis, in terms of side effects, instability of active ingredients, and skin penetration.
  • Pressure-Responsive, Surfactant-Free CO2-Based Nanostructured Fluids

    Microemulsions are extensively used in advanced material and chemical processing. However, considerable amounts of surfactant are needed for their formulation, which is a drawback due to both economic and
    ecological reasons.

     

  • NANOMOL Group accredited with the TECNIO certification

    NANOMOL Group has been accredited with the TECNIO certification as a Technology Developer Organization, until 2019.

Presentation